Valuation Omeros Corporation

Stocks

Market Closed - Nasdaq Other stock markets 23:00:00 31/07/2026 +03			5-day change	1st Jan Change
11.84 ^USD	-0.75%		+20.94%	-31.06%

06-26	Omeros Corporation Provides Update On European Marketing Authorization Application For Narsoplimab In TA-TMA	CI
06-26	Omeros to Seek EMA Review After Negative Opinion on Narsoplimab Marketing Application	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	402.1	141.8	205.6	572.5	1,218	856.9	-	-
Change	-	-64.75%	45%	178.51%	112.69%	-29.63%	-	-
Enterprise Value (EV)	587.5	284.6	205.6	572.5	1,218	856.9	856.9	856.9
Change	-	-51.56%	-27.76%	178.51%	112.69%	-29.63%	0%	0%
P/E	2.06x	2.97x	-1.74x	-3.66x	-344x	-197x	154x	13.1x
PBR	17x	1.66x	-	-	-	-	-	-
PEG	-	-0x	0x	-0.1x	3.5x	-9.9x	-1x	0x
Capitalization / Revenue	3.6x	-	-	-	-	12.6x	5.99x	3.23x
EV / Revenue	0x	-	-	-	-	12.6x	5.99x	3.23x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-12.1x	-60.6x	9.26x
EV / FCF	-	-	-	-	-	-	-408,059,144x	5,257,204x
FCF Yield	-	-	-	-	-	-	-0%	0%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	3.12	0.76	-1.88	-2.7	-0.05	-0.06	0.0767	0.9033
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	111.8	-	-	-	-	67.83	143.1	265.4
EBITDA	-172.2	-162.4	-	-	-	-	-	-
EBIT ¹	-173.6	-163.4	-164.5	-169.3	-122.8	-70.6	-14.13	92.57
Net income ¹	194.2	47.42	-117.8	-156.8	-3.35	-12.1	1.25	16.15
Net Debt	185.3	142.8	-	-	-	-	-	-
Reference price ²	6.43	2.26	3.27	9.88	17.18	11.84	11.84	11.84
Nbr of stocks (in thousands)	62,542	62,730	62,865	57,950	70,900	72,375	-	-
Announcement Date	3/1/22 A	3/13/23 A	4/1/24 A	3/31/25 A	3/31/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
OMEROS CORPORATION	-197.33x	-	-	-	857M
WUXI APPTEC CO., LTD.	21.25x	6.51x	14.24x	1.5%	56.54B
ARGENX SE	31.6x	7.8x	24.02x	0.05%	53.6B
BIONTECH SE	-17.91x	4.18x	-7.32x	-.--%	22.91B
INSMED INCORPORATED	-38.6x	12.23x	-36.05x	-.--%	21.37B
WUXI BIOLOGICS (CAYMAN) INC.	25.45x	4.98x	13.18x	-.--%	20.27B
GENMAB A/S	24.28x	4.73x	15.36x	-.--%	17.56B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-737.38x	35.03x	-3943.97x	-.--%	14.75B
EXELIXIS, INC.	16.68x	4.82x	11.24x	-.--%	13.33B
PHARMAESSENTIA CORPORATION	40.7x	16.37x	42.16x	0.09%	13.53B
Average	-83.13x	10.74x	-429.68x	0.18%	23.47B
Weighted average by Cap.	-32.67x	9.11x	-238.39x	0.38%